01Institutional qualificationOrganization, responsible contact and lawful intended use
02Written specificationIdentity, method, target, packaging and documentation
03Remetide lot recordManufacturer attribution and lot-specific analytical package
04Commercial reviewFeasibility, territory, logistics, lead time and quotation
Technical information
Record at a glance
Manufacturer
Remetide
Supply model
Quoted in 100 g increments; feasibility, schedule and yield confirmed in writing
Grade
Bulk research API; non-sterile
Illustrative target
≥99.7% by an approved molecule-appropriate chromatographic method; lot specification and result control
Identity support
LC-MS and chromatographic package under the approved batch record
Presentation
Bulk material in qualified primary packaging; configuration defined by quotation
Storage and transport
Defined by the approved material specification and shipment plan
Availability
Subject to qualification, feasibility and written quotation
Catalog number
SP-LS-API-BPC157-100G
Intended laboratory context
Illustrative applications
Analytical method development
Identity and retention-time comparison
In-vitro laboratory research
Approved non-clinical research manufacturing
Proposed package
Documentation
PDFManufacturer Certificate of AnalysisSample
PDFHPLC chromatogram and method summarySample
PDFMass-spectrometry identity summarySample
PDFMaterial specification and handling statementSample
PDFBatch traceability recordSample
Responsible-use statement
Quotation model for qualified institutional research only. No clinical, diagnostic, therapeutic, compounding, human or veterinary use. Final identity and salt form are controlled by the approved Remetide material specification.
Bulk API procurement
Begin with a controlled specification.
Reference SP-LS-API-BPC157-100G and provide the organization, intended non-clinical laboratory use, requested 100 g increments, target specification, analytical package, packaging, destination and required date.